Evidence map›Paper›PMID 36986677›Full record

ArticlePharmaceutics2023

Radioimmune Imaging of α

Alberto Signore, Rita Bonfiglio, Michela Varani, Filippo Galli, Giuseppe Campagna, Manuel Desco, Lorena Cussó, Maurizio Mattei, Andreas Wunder, Filippo Borri and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. A NovelPharmaceutics · 2025
    Article
  2. Review
  3. Challenges in IBD Research 2024: Precision Medicine.Inflammatory bowel diseases · 2024
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Alberto SignoreNuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0000-0001-8923-648X
Rita BonfiglioDepartment of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0003-4172-2977
Michela VaraniNuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0000-0002-7766-9031
Filippo GalliNuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0000-0002-3439-6010
Giuseppe CampagnaNuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0000-0002-1884-9171
Manuel DescoUnidad de Medicina y Cirugía Experimenta, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0003-0989-3231
Lorena CussóUnidad de Medicina y Cirugía Experimenta, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0001-9298-0015
Maurizio MatteiInterdepartmental Service Centre-Station for Animal Technology, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-0814-8873
Andreas WunderTranslational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, 88400 Biberach an der Riß, Germany.
Filippo BorriUnit of Pathological Anatomy, Department of Oncology, USL Toscana Sud-Est, San Donato Hospital, 52100 Arezzo, Italy.ORCID 0000-0002-5631-0724
Maria T LupoUnit of Pharmacy, University Hospital Sant'Andrea, 00185 Rome, Italy.
Elena BonannoDepartment of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.ORCID 0000-0002-0222-0141
Sapienza University of Rome · ITUniversity of Rome Tor Vergata · ITInstituto de Salud Carlos III · ESAzienda Ospedaliera Sant'Andrea · ITBoehringer Ingelheim (Germany) · DEOspedale San Donato · IT

Funding

DESIGNER DRUG INDUCED NEUROPATHOLOGYN01DA007403 · NIDA · NEW YORK UNIVERSITY · PI AZMITIG, EFRAIN · 1990 to 1992
–
Comunidad de Madrid S2022/BMD-7403 RENIM-CMInstituto de Salud Carlos III PT20/00044
6 · The paper itself

Abstract

Imaging using radiolabelled monoclonal antibodies can provide, non-invasively, molecular information which allows for the planning of the best treatment and for monitoring the therapeutic response in cancer, as well as in chronic inflammatory diseases. In the present study, our main goal was to evaluate if a pre-therapy scan with radiolabelled anti-α

Indexed as

DSS-mouse modelimaging inflammationinflammatory bowel diseaseTNFαα4β7 integrin

Identifiers

PMID36986677
PMCPMC10051745
OpenAlexW4322770032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.